A Strategy for Gallstone Expulsion Through Dietary Therapy
NCT06699030 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2025-12-31
Summary
This study is a double-blind, prospective, single-center controlled trial conducted at a tertiary hospital, aiming to determine whether dietary therapy can effectively expel gallstones.
Conditions
- Gallbladder Stone
Interventions
- DRUG
-
Functional fatty acids
Days 1-3: Oral Administration of functional fatty acids Days 4-6: Oral Administration of functional fatty acids
- OTHER
-
Placebo
Days 1-3: Placebo Days 4-6: Oral Administration of functional fatty acids
Sponsors & Collaborators
-
Hepatopancreatobiliary Surgery Institute of Gansu Province
lead OTHER
Principal Investigators
-
Wenbo Meng, M.D. · Hepatopancreatobiliary Surgery Institute of Gansu Province
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-24
- Primary Completion
- 2026-12-01
- Completion
- 2026-12-01
Countries
- China
Study Locations
More Related Trials
-
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
NCT02787668 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).
NCT07005752 ·Status: RECRUITING ·Phase: PHASE4
-
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 ·Status: COMPLETED ·Phase: NA
-
An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease
NCT05497765 ·Status: COMPLETED ·Phase: NA
-
Regulation of FGF21 by Nutritional Challenges
NCT00968747 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis
NCT02024295 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Probiotics on Non Alcoholic Fatty Liver Disease
NCT00808990 ·Status: TERMINATED ·Phase: PHASE1
-
Crassostrea Gigas for Liver Health
NCT02992470 ·Status: UNKNOWN ·Phase: NA
-
Tocotrienol Against the Progression of End Stage Liver Disease
NCT02581085 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD
NCT05897606 ·Status: COMPLETED ·Phase: PHASE1
-
The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)
NCT07303868 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression
NCT05291104 ·Status: COMPLETED ·Phase: NA
-
Effect of Polyphenol Supplementation on Hepatic Steatosis and Vascular Compliance
NCT03994029 ·Status: RECRUITING ·Phase: NA
-
Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease
NCT00007033 ·Status: COMPLETED ·Phase: NA
-
Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease
NCT05922332 ·Status: WITHDRAWN ·Phase: NA
-
The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty Liver
NCT01956825 ·Status: UNKNOWN ·Phase: PHASE4
-
Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07285135 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Early Enteral Nutrition for Severe Acute Pancreatitis
NCT00995098 ·Status: COMPLETED ·Phase: PHASE4
-
Interventional Strategy in Tackling Emerging Non-alcoholic Fatty Liver Disease in Childhood Obesity
NCT05905185 ·Status: COMPLETED ·Phase: PHASE4
-
Synbiotics Interventions for Managing Cirrhosis and Its Complications
NCT05687409 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver
NCT03319199 ·Status: COMPLETED ·Phase: NA
-
Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy
NCT03168555 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia
NCT06842966 ·Status: RECRUITING ·Phase: PHASE2
-
AST-120 Used to Treat Mild Hepatic Encephalopathy
NCT00867698 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis
NCT01998620 ·Status: UNKNOWN ·Phase: PHASE4